Effect of incretin related drugs on glucose metabolism and insulin secretion in cats
| Project/Area Number |
26850201
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Veterinary medical science
|
|---|
| Research Institution | Nippon Veterinary and Life Science University |
|---|
Principal Investigator |
Akihiro Mori 日本獣医生命科学大学, 獣医学部, 講師 (60549559)
|
|---|
| Research Collaborator |
SAKO Toshinori
ODA Hitomi
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 猫 / グルコース / インスリン / インクレチン / 肥満 / 糖尿病 |
|---|
| Outline of Final Research Achievements |
Impact of carbohydrate sources on short-term post-prandial serum glucose, insulin, and non-esterified fatty acid (NEFA) concentrations was investigated with obese cats. Ｍaltose appears to be capable of inducing experimentally induced postprandial hyperglycemia in obese cats. Next, effect on short-term post-prandial serum glucose, insulin, and incretin hormone concentrations in healthy cats treated by acarbose and sitaglipt and its combination therapy were investigated, following ingestion of a meal with maltose. Combination therapy offers great potential for treating diabetic cats.
|
Report
(4 results)
Research Products
(5 results)
